Integrin
-
Obtustatin
Catalog No. A17185 α1β1 抑制剂Obtustatin是高度有效的整联蛋白α1β1抑制剂(α1β1与IV型胶原的结合的IC 50 = 0.8 nM)。与α2β1,βIIbβ3,αvβ3,α4β1,β5β6,α9β1和α4β7相比,α1β1具有选择性。在鸡绒膜尿囊炎模型中抑制FGF2刺激的血管生成。在Lewis肺癌的协同小鼠模型中显示抗肿瘤功效;阻止人黑素瘤在裸鼠中的生长。 了解更多 -
TCS2314
Catalog No. A17193 -
BOP sodium salt
Catalog No. A17201 -
A-205804
Catalog No. A13047 -
Zaurategrast (CDP323)
Catalog No. A11614 VCAM-1 拮抗剂Zaurategrast (CDP323)是与α4-整合素结合的血管细胞粘附分子1的小分子前药拮抗剂。 了解更多 -
Cilengitide
Catalog No. A12372 Integrin 抑制剂Cilengitide是一种具有潜在抗肿瘤活性的环状精氨酸-甘氨酸-天冬氨酸肽。西仑吉肽结合并抑制α(v)β(3)和α(v)β(5)整联蛋白的活性,从而抑制内皮细胞-细胞相互作用、内皮细胞-基质相互作用和血管生成。 了解更多 -
Cilengitide trifluoroacetate
Catalog No. A12371 Integrin 抑制剂Cilengitide trifluoroacetate是一种具有潜在抗肿瘤活性的环状精氨酸-甘氨酸-天冬氨酸肽。西仑吉肽结合并抑制α(v)β(3)和α(v)β(5)整联蛋白的活性,从而抑制内皮细胞-细胞相互作用、内皮细胞-基质相互作用和血管生成。 了解更多 -
Firategrast (SB 683699)
Catalog No. A12787 α4β1/α4β7 integrin 拮抗剂Firategrast (SB 683699)是一种口服可生物利用的alpha4 beta1/alpha4 beta7整联蛋白拮抗剂,旨在减少淋巴细胞向中枢神经系统(CNS)的运输。 了解更多 -
Leukadherin 1
Catalog No. A13968 Integrin 激动剂Leukadherin 1是CD11b/CD18的变构激活剂。增加CD11b/CD18依赖性细胞对血纤蛋白原的粘附(EC50 = 4μM)。 了解更多 -
Cyclo (-RGDfK)
Catalog No. A14923 -
RGD (Arg-Gly-Asp) Peptides
Catalog No. A15538 Inhibits integrin binding to RGD motifsRGD (Arg-Gly-Asp) Peptides是一种细胞粘附基序,可以模拟细胞粘附蛋白并与整联蛋白结合。 了解更多 -
Cyclo (RGDyK) trifluoroacetate
Catalog No. A15918 -
Integrin Antagonists 27
Catalog No. A20895 integrin αvβ3 antagonistIntegrin Antagonists 27 is a small molecule integrin αvβ3 antagonist with binding affinity of 18 nM, as s novel anticancer agent. 了解更多 -
ATN-161 trifluoroacetate salt
Catalog No. A21412 integrin α5β1 antagonistATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model. 了解更多 -
Carotegrast
Catalog No. A21997 α4 integrin receptor inhibitorCarotegrast is an orally available α4 integrin receptor inhibitor with anti-inflammatories activities. 了解更多 -
Cyclo(RGDyK)
Catalog No. A21819 αVβ3 integrin inhibitorCyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with an IC50 of 20 nM. 了解更多